GO-Pen The first universal and price-neutral insulin pen
- Coordinator
- Go-Pen Aps, Denmark
- Runs
- 1 March 2023 to 31 August 2025
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €4.6m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190178477
What the project is doing
In the project's own words, from its summary on CORDIS.
The challenge for many people with diabetes (PwD) is that they dont get the right dose of insulin at the right time. This can potentially give long term health issues, and even shorten their lifetime. Today, this is an everyday challenge for more than 13 million people that still inject insulin with a 100 years old outdated technology (syringes and needles) and cannot afford branded insulin and modern pens. GO-Pen ApS developed the 1st affordable, safe, and sustainable insulin injection system that fits the unmet health needs in the worlds most resource constrained population.
The UNIPEN system innovation relies on the possibility of refilling a disposable cartridge with any kind of insulin available, resulting in a cost-competitive device to syringes solution improving the accuracy. Now, with the support of the EIC-A funding, we intend to refine the design of the UNIPEN device, demonstrate its design and clinical usability, and fine-tune the scale-up production.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Go-Pen Aps | Kongens Lyngby | Denmark | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI